US FDA asks Sun Pharma to stop trial on dermatological drug citing potential of blood clots
Sun Pharma acquired deuruxolitinib when it bought Concert Pharmaceuticals for $576 million earlier this year
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.